report-bg

Dermatology Medical Device Market

Segmentation by Product Type (Lasers, Fractional, Infrared, Pulsed, and Others); by End-User (Hospitals, Private Clinics, and Specialty Dermatology Clinics); and by Application (Vascular Lesions, Hair Removal, Wrinkle Removal, Acne Treatment, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now
Report ID: 229 | Published On: Jun 03, 2022
Request Free Sample Copy

Global Dermatology Medical Device Market Regional Synopsis

Regionally, the global dermatology medical device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. The market in the North America region is estimated to witness noteworthy growth over the forecast period on the back of the presence of a well-established healthcare infrastructure. Furthermore, the data published by the American Academy of Dermatology Association acne is a prominent skin condition in the USA which is affecting up to 50 million Americans annually. On the back of the rising number of people with acne conditions global dermatology medical device market is estimated to witness significant growth during the forecast period. Moreover, according to another data released by the American Academy of Dermatology Association, in the USA more than 9500 people are diagnosed with skin cancer disease every day, while more than 1 million Americans are living with melanoma, as of 2019. On the back rising emergence of patients with skin cancer disease in the US, the global dermatology medical device market is expected to witness significant growth in the region during the forecast period.

The global dermatology medical device market is projected to grow during the forecast period in the Europe region on the back of the growing geriatric population. Also, the government guidelines are flexible in the region which is the reason the global dermatology medical device market is expected to witness remarkable growth during the forecast period. Moreover, availability of advanced healthcare facilities in the region is further anticipated to boost the market growth.

Dermatology Medical Device Market Share

Get more information on this report: Download Sample PDF

The global dermatology medical device market is further classified on the basis of region as follows: 

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook 

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 


Dermatology Medical Device Market
Get more information on this report: Request Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth
cscs

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Market Segmentation 

Our in-depth analysis of the global dermatology medical device market includes the following segments:  

By Product Type 

  • Laser
  • Fractional
  • Infrared
  • Pulsed
  • Others 

By End-User  

  • Hospitals
  • Private Clinics
  • Specialty Dermatology Clinics 

By Application

  • Vascular Lesions
  • Hair Removal
  • Wrinkle Removal
  • Acne Treatment
  • Others


Growth Drivers  
  • Surging Cases of Skin Cancer
  • Growing Inclination Towards Aesthetic Beauty


Challenges  

  • Exorbitant Cost of the Treatment

Healthcare Expenditure per Capita, (USD), 2015-2018
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market 

    • Alma Lasers Ltd.
      • Company Overview 
      • Business Strategy 
      • Key Product Offerings 
      • Financial Performance 
      • Key Performance Indicators 
      • Risk Analysis 
      • Recent Development 
      • Regional Presence 
      • SWOT Analysis 
    • Bausch Health Companies Inc.
    • Cutera, Inc.
    • Canfield Scientific, Inc.
    • Aesthetic Group
    • Cynosure LLC
    • Lumenis Be Ltd.
    • Candela Corporations
    • Image Derm Inc.
    • Medtronic pl

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the dermatology medical device market?

Ans: The growing cases of skin cancer are estimated to be the major factors driving the growth of the global dermatology medical device market during the forecast period.

2) What would be the CAGR of dermatology medical device market over the forecast period?

Ans: The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2022 - 2031.

5) Who are the major players dominating the dermatology medical device market?

Ans: The major players in the market are Cynosure LLC, Lumenis Be Ltd., Candela Corporations, and Image Derm Inc.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the dermatology medical device market?

Ans: The market is segmented by product type, end-user, application and by region.

8) Which sub-segment captures the largest market size in the application segment in the dermatology medical device market?

Ans: The hair-removal segment is anticipated to hold the largest market size over the forecast period and display significant growth opportunities.

8) What are the challenges affecting the market growth?

Ans: The high cost of treatment is estimated to hamper the market growth.

8) Which region will provide more business opportunities for the growth of the dermatology medical device market in the future?

Ans: The North America region is expected to provide more business opportunities for growth of global dermatology medical device market during the forecast period.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample